Blood arsenic levels and the risk of familial breast cancer in Poland.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
15 05 2020
Historique:
received: 20 12 2018
revised: 05 06 2019
accepted: 18 06 2019
pubmed: 28 7 2019
medline: 23 9 2020
entrez: 27 7 2019
Statut: ppublish

Résumé

Arsenic is recognized as a potent carcinogen at high concentrations, but the relationship between environmental arsenic and breast cancer risk has not well been studied. Most research has focused on the effect of arsenic in populations with high endemic exposure, and not in populations with arsenic levels within normal limits. We sought to determine if blood arsenic levels predict the risk of breast and other cancers risk among women in northern Poland. The cohort consisted of 1,702 healthy women, aged 40 and above, identified between 2010 and 2017. Blood arsenic level was determined by inductively coupled plasma mass spectrometry. After an average of 4.5 years of follow-up (range 0.7-7.3 years), there were 110 incident cases of cancer diagnosed in the cohort, including 68 cases of breast cancer. Women in the highest quartile of arsenic had a highly significant 13-fold increased risk of developing breast cancer, compared to women in the lowest quartile (hazard ratio [HR] = 13.2; 95% confidence interval [CI] 4.02-43.0). Results were similar for arsenic and all incident cancers (HR quartile 4 vs. quartile 1 = 13.3; 95% CI 4.78-37.0). If confirmed, our study suggests that the blood arsenic level may be a useful predictive marker of cancer risk in women.

Identifiants

pubmed: 31348523
doi: 10.1002/ijc.32595
pmc: PMC7154768
doi:

Substances chimiques

Arsenic N712M78A8G

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2721-2727

Informations de copyright

© 2019 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.

Références

J Prev Med Public Health. 2014 Sep;47(5):245-52
pubmed: 25284195
Crit Rev Food Sci Nutr. 2016;56(6):979-88
pubmed: 25486051
Environ Health Perspect. 2006 Nov;114(11):1790-6
pubmed: 17107869
Clin Med Insights Oncol. 2014 Jan 09;8:1-13
pubmed: 24453505
N Engl J Med. 2015 Jun 4;372(23):2243-57
pubmed: 26014596
Salud Publica Mex. 2016 Apr;58(2):220-7
pubmed: 27557380
Environ Res. 2015 Nov;143(Pt B):29-45
pubmed: 26123540
Environ Health Perspect. 2008 Feb;116(2):231-7
pubmed: 18288323
Rev Environ Health. 2017 Sep 26;32(3):267-277
pubmed: 28284039
Biol Trace Elem Res. 2010 Aug;136(2):127-39
pubmed: 20195925
J Trace Elem Med Biol. 2015;31:249-59
pubmed: 25666158
IARC Monogr Eval Carcinog Risks Hum. 2004;84:1-477
pubmed: 15645577
J Radioanal Nucl Chem. 2014 Mar;299(3):1555-1563
pubmed: 26300575
Clin Chim Acta. 2015 Jan 15;439:178-84
pubmed: 25446879
Am J Epidemiol. 1996 Oct 1;144(7):653-60
pubmed: 8823061
Epidemiology. 2015 May;26(3):365-73
pubmed: 25760782
Nat Rev Cancer. 2016 Sep;16(9):599-612
pubmed: 27515922
Postgrad Med J. 2003 Jul;79(933):391-6
pubmed: 12897217
Cancer Causes Control. 2007 Feb;18(1):7-27
pubmed: 17186419
Cancer Manag Res. 2018 Jan 10;10:69-79
pubmed: 29391828
Environ Res. 2013 Jan;120:7-17
pubmed: 22999706
Toxicol Appl Pharmacol. 2009 Dec 15;241(3):269-74
pubmed: 19766132
Sci Total Environ. 2013 Oct 1;463-464:836-44
pubmed: 23867847
Biol Trace Elem Res. 2009 Summer;129(1-3):28-35
pubmed: 19043675
J Hazard Mater. 2009 Jun 15;165(1-3):652-63
pubmed: 19062162
Int J Environ Health Res. 2012;22(3):220-31
pubmed: 22017596
Hum Genet. 2009 Jun;125(5-6):507-25
pubmed: 19357868
Toxicol Appl Pharmacol. 2014 Oct 1;280(1):53-9
pubmed: 25062773
Int J Cancer. 2016 Feb 1;138(3):555-64
pubmed: 26219234
Int J Environ Res Public Health. 2011 Mar;8(3):861-74
pubmed: 21556183
Am J Clin Nutr. 2006 Nov;84(5):1093-101
pubmed: 17093162
Epidemiology. 2019 Jan;30(1):20-28
pubmed: 30198937
Environ Toxicol Pharmacol. 2017 Dec;56:106-113
pubmed: 28889078
Environ Mol Mutagen. 2017 Jul;58(6):411-422
pubmed: 28640505
J Natl Cancer Inst. 2018 Mar 1;110(3):241-249
pubmed: 29069505
J Prev Med Public Health. 2014 Sep;47(5):253-7
pubmed: 25284196
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2012;30(3):189-224
pubmed: 22970719
Am J Clin Nutr. 2007 Oct;86(4):1202-9
pubmed: 17921403
Environ Int. 2012 Feb;39(1):150-71
pubmed: 22208756
Environ Health Perspect. 2009 Feb;117(2):254-60
pubmed: 19270796
Lancet Oncol. 2017 Aug;18(8):e472-e482
pubmed: 28759386
Toxicol Sci. 2007 Jul;98(1):75-86
pubmed: 17283378
Sci Total Environ. 2017 Feb 15;580:266-282
pubmed: 28024743
Biol Trace Elem Res. 2011 Dec;144(1-3):360-79
pubmed: 21660533
Reprod Biol Endocrinol. 2010 Jul 02;8:80
pubmed: 20598115

Auteurs

Wojciech Marciniak (W)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Read-Gene SA, Grzepnica, Poland.

Róża Derkacz (R)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Read-Gene SA, Grzepnica, Poland.

Magdalena Muszyńska (M)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Read-Gene SA, Grzepnica, Poland.

Piotr Baszuk (P)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Read-Gene SA, Grzepnica, Poland.

Jacek Gronwald (J)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Read-Gene SA, Grzepnica, Poland.

Tomasz Huzarski (T)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Read-Gene SA, Grzepnica, Poland.
Department of Clinical Genetics and Pathology, University of Zielona Góra, Zielona Góra, Poland.

Cezary Cybulski (C)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Read-Gene SA, Grzepnica, Poland.

Anna Jakubowska (A)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Read-Gene SA, Grzepnica, Poland.

Michał Falco (M)

Radiation Oncology Department, West Pomeranian Oncology Center, Szczecin, Poland.

Tadeusz Dębniak (T)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Read-Gene SA, Grzepnica, Poland.

Marcin Lener (M)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.

Oleg Oszurek (O)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.

Katherine Pullella (K)

Women's College Research Institute, Toronto, Ontario, Canada.

Joanne Kotsopoulos (J)

Women's College Research Institute, Toronto, Ontario, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Ping Sun (P)

Women's College Research Institute, Toronto, Ontario, Canada.

Steven A Narod (SA)

Women's College Research Institute, Toronto, Ontario, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Jan Lubiński (J)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Read-Gene SA, Grzepnica, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH